It is demonstrated that Egfr knockout during the critical period of neuronal maturation results in a transient absence of astrocytes, with recovery observed in adult mice, and developmental disruption of EGFR signaling leads to transient astrocyte loss and impaired astrocyte–neuron crosstalk.
Abstract
Neural functions and circuit formation rely on intricate crosstalk among various cell types during critical periods. Disruptions or delays in this crosstalk between neurons and astrocytes lead to abnormal neural functions and neurodevelopmental disorders. However, the lack of robust mouse models to study the crosstalk between astrocytes and neurons thus renders unclear the implications of impeding such interactions. In this study, we demonstrate that Egfr knockout during the critical period of neuronal maturation results in a transient absence of astrocytes, with recovery observed in adult mice. This model thus provides a unique opportunity to investigate the effects of impaired astrocyte-neuron communication during development. Mechanically, we show that loss of Egfr disrupts the Egfr-pERK-Epb41l2 signaling axis, which in turn prevents glial progenitor cells from migrating outward. More importantly, Egfr deficiency during the critical period compromises astrocyte-neuron communication via the Sema6a-Plxna2/4 ligand-receptor pair. This impaired intercellular crosstalk reduces neuronal dendritic complexity and excitability, ultimately culminating in depressive-like behaviors in adult mice. This study shows that developmental disruption of EGFR signaling leads to transient astrocyte loss and impaired astrocyte–neuron crosstalk. Altered EGFR–pERK–EPB41L2 signaling and Sema6a–Plxna2/4 communication, results in reduced dendritic complexity, neuronal excitability, and long-term depressive-like behaviours.
Rett syndrome (RTT) is a severe X-linked neurodevelopmental disorder caused by loss-of-function mutations in the MECP2 gene and characterized by profound impairments in neuronal maturation and synaptic connectivity. Increasing evidence indicates that astrocyte dysfunction contributes to RTT pathogenesis through non-cel...
Francesca M. Postogna, Noemi Giancroce, C. Cabasino et al.· bioRxiv· 0 citations
Data show that LRRK2-G2019S impairs astrocyte specification and predisposes to a senescent phenotype, which contributes to the acquisition of a senescent-like phenotype in Parkinson’s disease patients.
Lisa M. Smits, S. Magni, K. Grzyb et al.· npj Parkinson's Disease· 0 citations
It is shown that neurogenesis is disrupted at multiple stages of lineage progression in both rodent and human neural stem cell models of Huntington's disease, and a panel of clinically relevant epigenetic compounds hold promise for stage-spanning therapeutic strategies capable of modifying disease trajectory.
Jessica Rosati, A. Casamassa, G. Ruotolo et al.· Cell Death and Differentiati...· 0 citations
This study demonstrates that increased secretion of LCN2 from hippocampal astrocytes in SAE mice binds to the neuronal receptor 24p3R, thereby inducing neuronal damage and suggests an etiopathogenic mechanism of SAE, initiated by the increased astrocytic secretion of LCN2.
Cui-Ping Guo, Yi Liu, Wensheng Li et al.· Cell Death and Differentiati...· 0 citations
The P2Y1R-IGFBP2 signaling axis is identified as a common pathological feature of reactive astrocytes across brain diseases and IGFBP2 is established as a novel glial-derived factor that could promote neuronal hyperexcitability.
E. Shigetomi, Schuichi Koizumi· Nihon yakurigaku zasshi. Fol...· 0 citations
The results demonstrate that EPM1 COs display increased electrophysiological activity and disrupted excitatory/inhibitory (E/I) balance, and identify the CSTB-SHH-EV axis as a potential therapeutic target for mitigating the E/I imbalance associated with EPM1.
Andrea Forero, V. Pravata, Fabrizia Pipicelli et al.· Science Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.